特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

COVID-19現行治療法の世界市場 - COVID-19による成長と変化:2020年

Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change

発行 The Business Research Company 商品コード 950447
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
COVID-19現行治療法の世界市場 - COVID-19による成長と変化:2020年 Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change
出版日: 2020年07月17日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界のCOVID-19現行治療法市場について調査分析し、市場の特徴・規模と成長・セグメンテーション、地域別・国別の内訳、競合情勢、市場シェア、動向と戦略などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 COVID-19現行治療法市場の特徴

第3章 COVID-19現行治療法市場規模と成長

  • 世界のCOVID-19現行治療法市場実績 (金額)
    • 市場促進要因
    • 市場抑制要因
  • 世界のCOVID-19現行治療法市場予測 (金額)
    • 市場促進要因
    • 市場抑制要因

第4章 COVID-19現行治療法市場セグメンテーション

  • 世界のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
    • 抗ウイルス薬(レムデシビル、リトナビル、ロピナビル)
    • 抗マラリア薬(ヒドロキシクロロキン)
    • インターフェロン(インターフェロンベータ)
    • コルチコステロイド(デキサメタゾン)
    • その他
  • 世界のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)
    • 病院
    • クリニック
    • 研究機関
    • その他

第5章 COVID-19現行治療法市場の地域別・国別分析

  • 世界のCOVID-19現行治療法市場:地域別、実績と予測 (金額)
  • 世界のCOVID-19現行治療法市場:国別、実績と予測 (金額)

第6章 アジア太平洋のCOVID-19現行治療法市場

  • アジア太平洋のCOVID-19現行治療法市場概要
  • アジア太平洋のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • アジア太平洋のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第7章 中国のCOVID-19現行治療法市場

  • 中国のCOVID-19現行治療法市場概要
  • 中国のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 中国のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第8章 インドのCOVID-19現行治療法市場

  • インドのCOVID-19現行治療法市場概要
  • インドのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • インドのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第9章 日本のCOVID-19現行治療法市場

  • 日本のCOVID-19現行治療法市場概要
  • 日本のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 日本のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第10章 オーストラリアのCOVID-19現行治療法市場

  • オーストラリアのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • オーストラリアのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第11章 インドネシアのCOVID-19現行治療法市場

  • インドネシアのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • インドネシアのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第12章 韓国のCOVID-19現行治療法市場

  • 韓国のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 韓国のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第13章 西欧のCOVID-19現行治療法市場

  • 西欧のCOVID-19現行治療法市場概要
  • 西欧のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 西欧のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第14章 英国のCOVID-19現行治療法市場

  • 英国のCOVID-19現行治療法市場概要
  • 英国のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 英国のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第15章 ドイツのCOVID-19現行治療法市場

  • ドイツのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • ドイツのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第16章 フランスのCOVID-19現行治療法市場

  • フランスのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • フランスのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第17章 東欧のCOVID-19現行治療法市場

  • 東欧のCOVID-19現行治療法市場概要
  • 東欧のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 東欧のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第18章 ロシアのCOVID-19現行治療法市場

  • ロシアのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • ロシアのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第19章 北米のCOVID-19現行治療法市場

  • 北米のCOVID-19現行治療法市場概要
  • 北米のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 北米のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第20章 米国のCOVID-19現行治療法市場

  • 米国のCOVID-19現行治療法市場概要
  • 米国のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 米国のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第21章 南米のCOVID-19現行治療法市場

  • 南米のCOVID-19現行治療法市場概要
  • 南米のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 南米のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第22章 ブラジルのCOVID-19現行治療法市場

  • ブラジルのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • ブラジルのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第23章 中東のCOVID-19現行治療法市場

  • 中東のCOVID-19現行治療法市場概要
  • 中東のCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • 中東のCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第24章 アフリカのCOVID-19現行治療法市場

  • アフリカのCOVID-19現行治療法市場概要
  • アフリカのCOVID-19現行治療法市場:薬剤タイプ別、実績と予測 (金額)
  • アフリカのCOVID-19現行治療法市場:エンドユーザー別、実績と予測 (金額)

第25章 COVID-19現行治療法市場の競合情勢と企業プロファイル

  • COVID-19現行治療法市場の競合情勢
  • COVID-19現行治療法市場の企業プロファイル
    • Moderna Therapeutics
    • Novavax
    • Bravovax
    • Ascletis Pharma
    • Altimmune

第26章 COVID-19現行治療法市場における主要なM&A

第27章 COVID-19現行治療法市場の動向と戦略

第28章 COVID-19現行治療法市場の将来見通しと潜在的分析

第29章 付録

目次

Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global coronavirus (covid-19) current therapy market.

This report focuses on coronavirus (covid-19) current therapy market which is experiencing strong growth. The report gives a guide to the coronavirus (covid-19) current therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the coronavirus (covid-19) current therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Coronavirus (COVID-19) Current Therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider coronavirus (covid-19) current therapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The coronavirus (covid-19) current therapy market section of the report gives context. It compares the coronavirus (covid-19) current therapy market with other segments of the coronavirus (covid-19) current therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, coronavirus (covid-19) current therapy market indicators comparison.

Scope

Markets Covered: 1) By Drug Type: Remdesivir; Hydroxychloroquine; Ritonavir; Lopinavir; Interferon Beta; Others

2) By End User: Hospitals; Clinics; Research Institutes; Others

Companies Mentioned: Moderna Therapeutics; Novavax; Bravovax; Ascletis Pharma; Altimmune

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Coronavirus (COVID-19) Current Therapy Market Characteristics

3. Coronavirus (COVID-19) Current Therapy Market Size And Growth

  • 3.1. Global Coronavirus (COVID-19) Current Therapy Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Coronavirus (COVID-19) Current Therapy Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Coronavirus (COVID-19) Current Therapy Market Segmentation

  • 4.1. Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Antiviral (Remdesivir; Ritonavir; Lopinavir)
    • Antimalarial (Hydroxychloroquine)
    • Interferons (Interferon Beta)
    • Corticosteroid (Dexamethasone)
    • Others
  • 4.2. Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Research Institutes
    • Others

5. Coronavirus (COVID-19) Current Therapy Market Regional And Country Analysis

  • 5.1. Global Coronavirus (COVID-19) Current Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Coronavirus (COVID-19) Current Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market

  • 6.1. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market Overview
  • 6.2. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Coronavirus (COVID-19) Current Therapy Market

  • 7.1. China Coronavirus (COVID-19) Current Therapy Market Overview
  • 7.2. China Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Coronavirus (COVID-19) Current Therapy Market

  • 8.1. India Coronavirus (COVID-19) Current Therapy Market Overview
  • 8.2. India Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Coronavirus (COVID-19) Current Therapy Market

  • 9.1. Japan Coronavirus (COVID-19) Current Therapy Market Overview
  • 9.2. Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Coronavirus (COVID-19) Current Therapy Market

  • 10.1. Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Coronavirus (COVID-19) Current Therapy Market

  • 11.1. Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Coronavirus (COVID-19) Current Therapy Market

  • 12.1. South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Coronavirus (COVID-19) Current Therapy Market

  • 13.1. Western Europe Coronavirus (COVID-19) Current Therapy Market Overview
  • 13.2. Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Coronavirus (COVID-19) Current Therapy Market

  • 14.1. UK Coronavirus (COVID-19) Current Therapy Market Overview
  • 14.2. UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Coronavirus (COVID-19) Current Therapy Market

  • 15.1. Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Coronavirus (COVID-19) Current Therapy Market

  • 16.4. France Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Coronavirus (COVID-19) Current Therapy Market

  • 17.1. Eastern Europe Coronavirus (COVID-19) Current Therapy Market Overview
  • 17.2. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Coronavirus (COVID-19) Current Therapy Market

  • 18.1. Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Coronavirus (COVID-19) Current Therapy Market

  • 19.1. North America Coronavirus (COVID-19) Current Therapy Market Overview
  • 19.2. North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Coronavirus (COVID-19) Current Therapy Market

  • 20.1. USA Coronavirus (COVID-19) Current Therapy Market Overview
  • 20.2. USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Coronavirus (COVID-19) Current Therapy Market

  • 21.1. South America Coronavirus (COVID-19) Current Therapy Market Overview
  • 21.2. South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Coronavirus (COVID-19) Current Therapy Market

  • 22.1. Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Coronavirus (COVID-19) Current Therapy Market

  • 23.1. Middle East Coronavirus (COVID-19) Current Therapy Market Overview
  • 23.2. Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Coronavirus (COVID-19) Current Therapy Market

  • 24.1. Africa Coronavirus (COVID-19) Current Therapy Market Overview
  • 24.2. Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Coronavirus (COVID-19) Current Therapy Market Competitive Landscape And Company Profiles

  • 25.1. Coronavirus (COVID-19) Current Therapy Market Competitive Landscape
  • 25.2. Coronavirus (COVID-19) Current Therapy Market Company Profiles
    • 25.2.1. Moderna Therapeutics
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Novavax
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Bravovax
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Ascletis Pharma
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Altimmune
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Coronavirus (COVID-19) Current Therapy Market

27. Coronavirus (COVID-19) Current Therapy Market Trends And Strategies

28. Coronavirus (COVID-19) Current Therapy Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer